SCHEMBL22340920

SCHEMBL22340920

C=CCN(C/C=C(\C)CCC=C(C)C)CCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
SQLE Q14534 5/20 0.41
KMT2A Q03164 3/20 0.41
LSS P48449 1/20 0.39
ALOX15 P16050 3/20 0.39
CNR1 P21554 2/20 0.39
CNR2 P34972 2/20 0.39
TRPV1 Q8NER1 2/20 0.39
MEN1 O00255 2/20 0.39
CYP3A4 P08684 2/20 0.39
TRPA1 O75762 1/20 0.39
INHA P05111 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRM1 P35372 1/20 0.39
PPARG P37231 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340879 1.00 KDM4E (0.47) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL20871256 1.00 KDM4E (0.47) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL20871423 1.00 KDM4E (0.47) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL22340479 0.99 KDM4E (0.48) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL20871383 0.94 KDM4E (0.49) KDM4ESQLEKMT2AALOX15MEN1
SCHEMBL4719072 0.90 KDM4E (0.53) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL4719073 0.90 KDM4E (0.53) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL29336121 0.88 KDM4E (0.51) KDM4ESQLEKMT2AALOX15MEN1
SCHEMBL14273788 0.85 KDM4E (0.49) KDM4ESQLEKMT2ALSSALOX15
SCHEMBL4762055 0.85 KDM4E (0.49) KDM4ESQLEKMT2ALSSALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 KDM4E 2452/4885SQLE 57/4885KMT2A 1195/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A KDM4E 2466/4885SQLE 58/4885KMT2A 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.